A study investigating the functional capacity of sCTLA-4 for immunosuppression found that sCTLA-4 was able to reduce the proliferation of murine splenic CD8+ T cells in vitro and accelerate growth and experimental metastasis of murine tumours in vivo. This evidence concerns the gene CD8A and neoplasm.